Epigenomics AG (ECX) Stock Price, Quote & Financials

Price History

Previous Close0.87

Open0.87

Day Range0.87 – 0.88

52-Week Range0.83 – 1.59

Volume0

Market Cap6.62M

P/E (TTM)0.00

Forward P/E10.36

Dividend Yield0.00%

50-Day Avg0.882

200-Day Avg0.882

There is no Profile data available for ECX.SG.

Currency: EUR	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	4.20M	1.86M	1.53M	1.13M	842.00K	6.20M	898.00K	339.00K	0	24.00K
Growth (%)	-	-55.63%	-17.76%	-26.61%	-25.16%	+636.70%	-85.52%	-62.25%	-100.00%	-
Cost of Revenue	1.63M	263.00K	480.00K	268.00K	145.00K	136.00K	474.00K	57.00K	0	-
Gross Profit	2.57M	1.60M	1.05M	857.00K	697.00K	6.07M	424.00K	282.00K	0	-
Gross Margin	61.10%	85.89%	68.69%	76.18%	82.78%	97.81%	47.22%	83.19%	-	-
Operating Expense	15.01M	11.46M	14.35M	15.96M	10.81M	10.23M	16.27M	5.25M	3.41M	-
Operating Income	-12.44M	-9.86M	-13.29M	-15.10M	-10.11M	-4.16M	-15.85M	-4.96M	-3.41M	-333.00K
Operating Margin	-296.07%	-528.70%	-867.06%	-1342.40%	-1201.19%	-67.10%	-1765.03%	-1464.31%	-	-1387.50%
EBITDA	-	-9.93M	-12.57M	-13.99M	-11.07M	-1.94M	-10.20M	-3.38M	-1.06M	-314.00K
EBITDA Margin	-	-532.78%	-820.09%	-1243.56%	-1315.08%	-31.26%	-1136.30%	-997.05%	-	-1308.33%
Net Income	-11.16M	-10.23M	-12.69M	-17.02M	-11.69M	-2.43M	-17.30M	-4.46M	-3.35M	-314.00K
Net Income Margin	-265.67%	-549.09%	-827.92%	-1512.89%	-1387.89%	-39.14%	-1926.95%	-1316.81%	-	-1308.33%
R&D	5.12M	4.33M	6.42M	7.34M	3.66M	2.94M	6.19M	-	-	-
R&D as % of Total Revenue	121.85%	232.24%	418.66%	652.44%	434.56%	47.41%	689.42%	-	-	-
Interest Expense	0	0	550.00K	63.00K	55.00K	52.00K	84.00K	0.2	0	0
Interest Expense % of Total Revenue	0.00%	0.00%	35.88%	5.60%	6.53%	0.84%	9.35%	0.00%	-	0.00%

Currency: EUR	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	18.22M	19.77M	21.83M	13.99M	6.80M	24.66M	13.99M	12.85M	11.85M	11.62M
Total Liabilities	3.80M	9.20M	3.21M	4.36M	2.93M	2.54M	13.99M	12.85M	11.85M	11.61M
Total Equity	14.42M	10.58M	18.61M	9.63M	3.86M	22.12M	0	0	0	2.00K
Cash	11.53M	12.83M	16.46M	10.15M	3.57M	23.05M	7.80M	2.10M	927.00K	414.00K
Net Debt	-	-	-	-	-	-	4.85M	9.79M	10.46M	10.97M

Currency: EUR	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-13.28M	-9.58M	-10.35M	-13.51M	-9.57M	-4.15M	-10.63M	-5.71M	-1.20M	-533.00K
Capital Expenditure	1.27M	583.00K	106.00K	122.00K	21.00K	35.00K	138.00K	3.00K	0	0
Free Cash Flow	-	-10.16M	-10.46M	-13.63M	-9.59M	-4.19M	-10.76M	-5.71M	-1.20M	-533.00K
FCF to OCF	-	106.09%	101.02%	100.90%	100.22%	100.84%	101.30%	100.00%	100.00%	100.00%

Market Cap6.62M

Enterprise Value11.91M

Trailing P/E0.00

Forward P/E10.36

PEG Ratio0.00

Price / Sales1.59

Price / Book0.81

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets0.00%

Shares Outstanding0

Shares Float0

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%